In order to reduce the risk of biopsy-induced bleeding, especially for massive bleeding during bronchoscopy, it may be appropriate to maintain the levels of plasma ApoE between 3.5 mg/dL and 5.9 mg/dL prior to aggressive biopsy on endobronchial exophytic lesions in lung cancer patients. The gene discussed is APOE; the disease is lung cancer.